HEMATOLOGICAL MALIGNANCY
Clinical trials for HEMATOLOGICAL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Half-Matched stem cell transplant offers hope for blood cancer patients
Disease control Recruiting nowThis study tests a stem cell transplant using a half-matched (haploidentical) donor for people with blood cancers who don't have a fully matched donor. The approach uses chemotherapy and radiation before transplant, plus drugs like cyclophosphamide and bortezomib after to prevent…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE2 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Cord blood immune cells engineered to hunt blood cancers enter human testing
Disease control Recruiting nowThis study tests a new treatment using specially engineered natural killer (NK) cells from donated cord blood. The cells are designed to target a protein called CD5 found on certain blood cancer cells. About 64 people with relapsed or hard-to-treat blood cancers will receive thes…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 02, 2026 11:58 UTC